Prof Edward Byrne - Researcher Profile

Biography

Edward works in the Office of the VC & President at Monash University as a Vice-Chancellor & President.

Qualifications

FELLOW

Institution: College of Surgeons London

Year awarded: 2008

MASTER OF BUSINESS ADMINISTRATION

Institution: University of Queensland

Year awarded: 2005

FELLOW

Institution: Royal College of Physicians Edinburgh

Year awarded: 1998

DOCTOR OF SCIENCE

Institution: University of Melbourne

Year awarded: 1995

DOCTOR OF MEDICINE

Institution: University of Tasmania

Year awarded: 1982

FELLOW

Institution: Royal Australian College of Physicians

Year awarded: 1980

DIPLOMA OF CLINICAL SCIENCE

Institution: University of Adelaide

Year awarded: 1977

BACHELOR OF MEDICINE/BACHELOR OF SURGERY

Institution: University of Tasmania

Year awarded: 1974

BACHELOR OF MEDICAL SCIENCE

Institution: University of Tasmania

Year awarded: 1971

Publications

Journal Articles

Byrne, E., 2009, Clinical research in the United Kingdom: a new era., Medical Journal Of Australia [P], vol 190, issue 4, Australasian Medical Publishing Co. Ltd, Pyrmont, Australia, pp. 172-173.

Byrne, E., 2007, Should postgraduate training places be reserved for UK graduates? Yes, British Medical Journal [P], vol 335, issue 7620, British Medical Journal, London, UK, p. 590.

Williams, D.R., Reardon, K.A., Roberts, L., Dennett, X., Duff, R., Laing, N.G., Byrne, E., 2005, A new dominant distal myopathy affecting posterior leg and anterior upper limb muscles, Neurology, vol 64, issue 7, Lippincott Williams & Wilkins, Philadelphia USA, pp. 1245-1254.

Wong, S.H.A., Lowes, K.N., Quigley, A., Marotta, R., Kita, M., Byrne, E., Kornberg, A.J., Cook, M.J., Kapsa, R.M., 2005, DNA electroporation in vivo targets mature fibres in dystrophic mdx muscle, Neuromuscular Disorders [P], vol 15, issue 9, Pergamon, UK, pp. 630-641.

Marotta, R., Chin, J., Quigley, A., Katsabanis, S., Kapsa, R.M., Byrne, E., Collins, S., 2004, Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001, Internal Medicine Journal [P], vol 34, issue 1, Wiley-Blackwell Publishing Inc., Malden, USA, pp. 10-19.

Byrne, E., Kornberg, A.J., Kapsa, R.M., 2003, Duchenne muscular dystrophy: hopes for the sesquicentenary, Medical Journal Of Australia [P], vol 179, issue 9, Australasian Medical Publishing Co. Ltd, Pyrmont, Australia, pp. 463-464.

Mee, J., Paine, M., Byrne, E., King, J., Reardon, K., O'Day, J., 2003, Immunotherapy of ocular myasthenia gravis reduces conversion to generalised myasthenia gravis, Journal Of Neuro-Ophthalmology [P], vol 23, issue 4, Journal of Neuroophthalmology, Philadelphia, USA, pp. 251-255.

Kapsa, R.M., Kornberg, A.J., Byrne, E., 2003, Novel therapies for Duchenne muscular dystrophy, Lancet [P], vol 2, issue 5, Elsevier Ltd, New York, NY, USA, pp. 299-310.

Trounce, I., Feeney, C., Byrne, E., 2003, Pathoetiology of motor neuron disease: new insights from genetics and animal models, Journal of Clinical Neuroscience [P], vol 10, issue 3, Elsevier Science Ltd, Oxford, UK, pp. 293-296.

Byrne, E., Howells, D., 2003, Stem cell therapies: A tale of caution, Medical Journal Of Australia [P], vol 179, issue 3, Australasian Medical Publishing Co. Ltd, Pyrmont, Australia, pp. 164-166.

Feeney, S.J., Austin, L., Bennett, T., Kurek, J., Jean-Francois, B., Muldoon, C., Byrne, E., 2003, The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis., Cytokine [P], vol 23, Elsevier Ltd, London, UK, pp. 108-118.